Enovis (FRA:C520) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:C520 Enovis Corp FRA:C520
64 GF Score
Price €22.20
GF Value €42.43
! 6 Warning Signs
View Full Analysis

What is Enovis Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:C520 vs INSP, PRCT, AHCO: Short Interest Comparison

For the Medical Devices subindustry, Enovis's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enovis Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Enovis's Short Interest distribution charts can be found below:

* The bar in red indicates where Enovis's Short Interest falls into.


FRA:C520
64GF Score
Enovis Corp FRA:C520
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Enovis (FRA:C520) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of €22.20 is trading 47.7% below its estimated GF Value™ of €42.43.

Key valuation signals for FRA:C520:

  • Short Interest:
  • GF Value™: €42.43 vs. price of €22.20 (47.7% below fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the FRA:C520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
64GF Score

Get the complete analysis for FRA:C520

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.20
Price
€42.43
GF Value